Hengrui Pharma (Hengrui) and Braveheart Bio (Braveheart) today announced results from a multi-center, randomized, double-blind, placebo-controlled Phase 2 study evaluating HRS-1893 (also known as ...
Phase 3 ACACIA-HCM trial results show aficamten significantly improves exercise capacity and quality of life in patients with symptomatic non-obstructive HCM.
With over four years of experience writing in the housing market space, Robin Rothstein demystifies mortgage and loan concepts, helping first-time homebuyers and homeowners make informed decisions as ...
Andrea Riquier is a former Staff Writer at Forbes Advisor. She is a New York-based writer covering mortgages and the housing market. She was previously at Dow Jones MarketWatch, on the housing market ...
Maximo Quiles won the FIM Moto3 World Championship race Sunday at Circuit de Barcelona-Catalunya, in Spain. Using his Pirelli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results